首页> 外文期刊>Journal of international management >Breast implant-associated anaplastic large cell lymphoma: A rare case report of lymphoma in the form of a pericapsular solid formation
【24h】

Breast implant-associated anaplastic large cell lymphoma: A rare case report of lymphoma in the form of a pericapsular solid formation

机译:乳腺植入植入性的促进性大细胞淋巴瘤:一种近似固体形成形式的淋巴瘤的罕见报告

获取原文
获取原文并翻译 | 示例
       

摘要

Breast cancer is the most frequently diagnosed cancer in women in the western world and a major cause of premature death. Consequently, breast implants are widely used for breast reconstruction. Despite this, the prevalence of implant complications is low. Given widespread use of breast implants, there is an increased awareness of the risk for developing a breast implant associated- anaplastic large cell Lymphoma (BI-ALCL) although rare. Clinical presentation is variable and may include a palpable mass in the breast or axilla, generalized breast pain, or breast firmness. The estimated incidence of BI-ALCL is <3 per 1 million person years, approximately 0.1-0.3 per 100 000 women with prostheses per year. Since the publication by Keech and Creech in 1997, which reported the first case of BI-ALCL, an increasing number of BI-ALCL have appeared, in patients with both aesthetic and reconstructive indications. In this paper, we describe a patient who was diagnosed with invasive BIA-ALCL seventeen years after placement of silicone breast implants and was treated with only surgery.
机译:乳腺癌是西方世界妇女中最常见的癌症,以及过早死亡的主要原因。因此,乳房植入物广泛用于乳房重建。尽管如此,植入物并发症的患病率较低。鉴于乳房植入物的广泛使用,虽然罕见,但患有乳房植入血栓性大细胞淋巴瘤(Bi-AlCl)的风险的认识增加了。临床介绍是可变的,可包括乳房或腋窝,广义乳房疼痛或乳房固体的可触及物质。 Bi-Alcl的估计发生率为每年100万人,每10万名妇女每年约0.1-0.3岁,每年患有假体。自1997年Kech和Chereech的出版以来,其中报告了Bi-Alcl的第一种情况,患有审美和重建适应症的患者中出现了越来越多的Bi-AlCl。在本文中,我们描述了一名患者在放置硅氧烷乳房植入物后17年诊断为侵袭性Bia-Alcl,并仅用手术治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号